Oruka Therapeutics sharers are trading lower after a SEC filing disclosed that Fairmount Healthcare Fund II sold shares worth about $300 mil
Oruka Therapeutics sharers are trading lower after a SEC filing disclosed that Fairmount Healthcare Fund II sold shares worth about $300 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.